Why African pharmaceutical manufacturers struggle for sustainability

Universal Corporation Limited sits on the outskirts of Nairobi — a two-decade-old pharmaceutical manufacturing factory that produces over 100 formulations of human medicines, such as antibiotics, and drugs for malaria and HIV.

It’s the only World Health Organization-prequalified facility in Kenya. And recently, it became the first manufacturer in Africa to receive WHO approval to produce the antimalarial drug, sulfadoxine-pyrimethamine plus amodiaquine.

The company operates in about 22 African nations.

This story is forDevex Pro members

Unlock this story now with a 15-day free trial of Devex Pro.

With a Devex Pro subscription you'll get access to deeper analysis and exclusive insights from our reporters and analysts.

Start your free trial